Biovail names vice president of neurologic and psychiatric development

Dr Sussman brings a wealth of business and academic experience in the field of neurology and other central nervous system (CNS) disorders to Biovail.

Prior to joining Biovail, Dr Sussman was president of NMSNeuro Consulting, specializing in therapeutic areas such as dementia, mania, neuroprotection, multiple sclerosis and Parkinson’s disease. Before that, Dr Sussman was senior director of CNS clinical research at Kyowa Pharmaceutical, overseeing development-stage products in Parkinson’s disease.

Bill Wells, Biovail’s CEO, said: “We are delighted to have an individual as qualified as Dr Sussman join our medical and scientific affairs team. The addition of his expertise and experience in CNS disorders is an important step in the implementation of Biovail’s new strategic focus.”